Form 4: Astrana Health Executive Chairman Exercises Options

Kenneth T. Sim, Executive Chairman of Astrana Health, Inc., exercised stock options to acquire 29,502 shares of common stock at $17.78 per share.

Summary

• Kenneth T. Sim, Executive Chairman and Director of Astrana Health, Inc. (ASTH), acquired 29,502 shares of common stock.
• The acquisition occurred on November 10, 2025, through the exercise of fully vested stock options at a price of $17.78 per share.
• Following this transaction, Mr. Sim directly holds 639,407 shares of common stock, which includes 117,501 unvested restricted shares vesting in three equal annual installments starting March 5, 2026, and 133,333 unvested restricted shares vesting upon achievement of performance goals.
• Indirect beneficial ownership includes 6,132,802 shares through Allied Physicians of California, 546,349 shares through the Kenneth T & Simone S Sim Family Trust, 42,996 shares through the Kenneth T. Sim Pension Plan Trust, and 230,688 shares through a grantor retained annuity trust.
• Mr. Sim disclaims beneficial ownership of the indirectly held securities except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The exercise of stock options by a key executive is generally a positive signal, indicating confidence in the company's stock value and future prospects. It's a routine compensation event but still reflects an executive's decision to increase their direct stake.

Positives

• Executive Chairman Kenneth T. Sim exercised stock options, indicating continued alignment with the company's future performance and potential confidence in its stock value.
• The exercise price of $17.78 suggests the options were in-the-money, providing a personal financial gain for the executive upon exercise.

Future Outlook

The filing indicates future vesting schedules for unvested restricted stock, with 117,501 shares vesting in three equal annual installments beginning March 5, 2026, and 133,333 shares vesting upon achievement of certain pre-established performance goals. This suggests ongoing executive incentive alignment with future company performance.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

This insider transaction reflects a routine executive compensation event within the healthcare services industry, where equity-based incentives are common for aligning management interests with shareholder value. The exercise of options by a key executive like the Executive Chairman can be viewed as a positive signal regarding the company's near-term prospects, consistent with practices across publicly traded companies.

Comparison to Industry Standards

• The exercise of stock options by an executive is a standard component of executive compensation packages across various industries, including healthcare.
• While specific comparable companies or projects are not detailed in this Form 4, such transactions are common for executives at companies like UnitedHealth Group (UNH), CVS Health (CVS), or Humana (HUM), where equity incentives are used to motivate long-term performance and retention.
• The transaction itself does not provide specific performance metrics for direct comparison but aligns with typical executive equity activity.

Related Party Transactions

• Indirect beneficial ownership through Allied Physicians of California, a professional medical corporation where the Reporting Person is Chairman, a director, and a stockholder.
• Indirect beneficial ownership through the Kenneth T & Simone S Sim Family Trust.
• Indirect beneficial ownership through the Kenneth T. Sim Pension Plan Trust.
• Indirect beneficial ownership through a grantor retained annuity trust for the benefit of the Reporting Person and his children.

Stakeholder Impact

• Shareholders: The transaction indicates an executive's continued alignment with shareholder interests through increased equity ownership. The exercise of options at a specific price could be seen as a positive signal regarding the executive's view of the company's valuation.
• Employees: No direct impact on employees is mentioned, but executive compensation structures can influence overall company culture and morale.

Next Steps

• Vesting of 117,501 unvested restricted shares in three equal annual installments beginning March 5, 2026.
• Vesting of 133,333 unvested restricted shares upon achievement of certain pre-established performance goals.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned exercise of stock options by a key executive. While it demonstrates continued insider ownership and potential confidence, it does not present new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals rather than this specific insider transaction.

Keywords

Astrana Health, ASTH, Kenneth T. Sim, Executive Chairman, Stock Option Exercise, Insider Transaction, Beneficial Ownership, SEC Form 4, Equity Acquisition